Rule 5. (1) In addition to complying with the requirements of part 1 of these rules, a
pharmacy that performs or contracts for centralized prescription processing shall comply
with this rule if processing a prescription for a schedule 2, 3, 4, or 5 controlled substance.
(2) Prescriptions for controlled substances may be transmitted electronically, including
by facsimile, from an originating pharmacy to a central fill pharmacy.
(3) An originating pharmacy that transmits prescription information for a controlled
substance to a central fill pharmacy shall comply with all of the following:
(a) Ensure that the words "CENTRAL FILL" are on the face of the original prescription
and the originating pharmacy shall record all of the following information:
(i) The name, address, and the Federal Drug Enforcement Administration (DEA)
registration number of the central fill pharmacy where the prescription was transmitted.
(ii) The name of the pharmacist at the originating pharmacy who transmitted the
prescription.
(iii) The date of transmittal.
(b) Ensure that the information that is required on a prescription under 21 CFR 1306.05
and R 338.3161 is transmitted to the central fill pharmacy, either on the face of the
original prescription or in the electronic transmission of the prescription.
(c) Include all of the following in the prescription:
(i) The number of refills already dispensed.
(ii) The number of refills remaining.
(d) Maintain the original prescription for a period of 5 years from the date the
prescription was filled.
(4) Two years after the prescription was filled, the originating pharmacy may make an
electronic duplicate of the original printed prescription, which becomes the original
prescription. A pharmacy shall present a printed copy of the electronic duplicate of the
prescription to the department or board upon request.
(5) In addition to complying with the requirements in R 338.3054(2)(a), (b), (c), (d), (e),
(f) and (g), a central fill pharmacy that receives the transmitted prescription shall comply
with all of the following:
(a) Maintain records for 5 years after the date of transmittal.
(b) Maintain a copy of the prescription if it was sent via facsimile or an electronic
record of all the information transmitted by the originating pharmacy, including the
name, address, and DEA registration number of the originating pharmacy that transmitted
the prescription.
(c) Maintain a record of the date the filled prescription was dispensed and the method
of dispensing.
History: 2008 AACS; 2023 MR 10, Eff. May 19, 2023.
R 338.3056 Reporting to the electronic system for monitoring controlled substances.
Rule 6. As used in this part, the pharmacy that uses its stock to fill a prescription for a
controlled substance is the pharmacy responsible to report to the department or the
department's contractor the information required in R 338.3162b for each controlled
substance prescription.
History: 2008 AACS; 2023 MR 10, Eff. May 19, 2023.
Page 4